Catalyst Wire Dossier Catalyst Wire Dossier

Remternetug

LY3372993 · Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Remternetug, covering 2025-04-25 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Remternetug (LY3372993) in Healthy Chinese Participants [Phase 1]

See pricing